G. Deplanque

5.5k citations
74 papers · 4.4k · 2 hit papers · h-index 36

Impact in

  • Oncology top 2%
    • Pancreatic and Hepatic Oncology Research
    • Colorectal Cancer Treatments and Studies
    • Cancer Treatment and Pharmacology
    • Colorectal Cancer Surgical Treatments
    • Cancer Immunotherapy and Biomarkers
    • Prostate Cancer Treatment and Research
    • Prostate Cancer Diagnosis and Treatment

Papers in

    • Colorectal Cancer Treatments and Studies 12
    • Pancreatic and Hepatic Oncology Research 10
    • Colorectal Cancer Surgical Treatments 4
    • Cancer-related Molecular Pathways 4
    • Prostate Cancer Treatment and Research 12
    • Renal cell carcinoma treatment 4

G. Deplanque

73 papers receiving 4.2k citations

G. Deplanque's Hit Papers

Androgen Deprivation Therapy (ADT) Plus Docetaxel Versus ADT Alone in Metastatic Non castrate Prostate Cancer: Impact of Metastatic Burden and Long-term Survival Analysis of the Randomized Phase 3 GETUG-AFU15 Trial 2015 · 378 citations
3780+4+8Years since publication100200300400500

Peers

G. Deplanque
Comparison fields: 5 of 101
  • Oncology 1.4k
  • Pulmonary and Respiratory Medicine 1.6k
  • Reproductive Medicine 128
  • Dermatology 100
  • Cancer Research 158
Replace Salvatore Pisconti with:
Salvatore Pisconti Italy
Alessandra di Pietro United States
Atsuo Takashima Japan
Satoru Iwasa Japan
Lucas Vieira dos Santos Brazil
Jean‐Pascal Machiels Belgium
Paul S. Ritch United States
Jean-Pascal Machiels Belgium
Petr Zatloukal Czechia
Conrad R. Lewanski United Kingdom
G. Deplanque relative to Salvatore Pisconti Italy Salvatore Pisconti's profile →
Citations per field
00.5×2×3.4×
Salvatore Pisconti · 1×
Citations per year

Countries citing papers authored by G. Deplanque

Since Specialization
Citations

This map shows the geographic impact of G. Deplanque's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by G. Deplanque with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites G. Deplanque more than expected).

Fields of papers citing papers by G. Deplanque

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by G. Deplanque. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by G. Deplanque. The network helps show where G. Deplanque may publish in the future.

Co-authors

The 25 scholars most cited alongside G. Deplanque, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with G. Deplanque Line = papers co-authored together G. Deplanque links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown

Showing the 20 most-cited of 74 papers — load more, or switch the sort, to bring in the rest.

#Work
1
Androgen-deprivation therapy alone or with docetaxel in non-castrate metastatic prostate cancer (GETUG-AFU 15): a randomised, open-label, phase 3 trial
Hit paper breakdown →
2013575
2
Androgen Deprivation Therapy (ADT) Plus Docetaxel Versus ADT Alone in Metastatic Non castrate Prostate Cancer: Impact of Metastatic Burden and Long-term Survival Analysis of the Randomized Phase 3 GETUG-AFU15 Trial
Hit paper breakdown →
2015378
3 2018261
4 2005195
5 2015184
6 2011167
7 2014132
8 2020131
9 2018129
10 2011117
11
Efficacy and toxicity of the angiogenesis inhibitor SU5416 as a single agent in patients with advanced renal cell carcinoma, melanoma, and soft tissue sarcoma.
2003108
12 2014102
13 201794
14 201989
15 201386
16 200085
17 201585
18 200581
19 202275
20 201873

About G. Deplanque

G. Deplanque is a scholar working on Oncology, Pulmonary and Respiratory Medicine, Cancer Research, Hepatology and Dermatology, having authored 74 papers that have together received 4.4k indexed citations. Recurring topics across this work include Prostate Cancer Treatment and Research (12 papers), Colorectal Cancer Treatments and Studies (12 papers), Pancreatic and Hepatic Oncology Research (10 papers), Hepatocellular Carcinoma Treatment and Prognosis (4 papers), Colorectal Cancer Surgical Treatments (4 papers), Cancer-related Molecular Pathways (4 papers), Breast Cancer Treatment Studies (4 papers) and Renal cell carcinoma treatment (4 papers). The work is most often cited by research in Oncology (1.4k citations), Pulmonary and Respiratory Medicine (1.6k citations), Reproductive Medicine (128 citations), Dermatology (100 citations) and Cancer Research (158 citations). G. Deplanque has collaborated with scholars based in France, Switzerland and United Kingdom. Frequent co-authors include Adrian L. Harris, Stéphane Marie. Oudard, Gwénaëlle Gravis, Josep M. Tabernero, Philippe Beuzeboc, Stéphane Culine, Florence Joly, R. Delva, Denis Pezet and Éric François. Their work appears in journals such as Annals of Oncology, European Journal of Cancer, British Journal of Cancer, The Lancet Oncology and Clinical Cancer Research.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact